Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
106190.KQ
BUYHigh Tech Pharm Co., Ltd. · Healthcare · South Korea · $100M · Avg Vol: $427K/d
66
StockRankQ
62
V
60
M
33
P/E (TTM)
12.4x
ROE
7.2%
D/E
0.0x
Dividend %
1.1%
COMPANY DESCRIPTION
High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 67.0M | 50.0M | 50.5M | 45.7M | -12.0% |
| EPS | 0.24 | 0.49 | 0.84 | 0.70 | 43.1% |
| Shares | 10.6M | 7.1M | 10.6M | 10.6M | -0.0% |
| Debt | 10.7M | 10.7M | 5.2M | 21,889 | -87.3% |
| Equity | 65.1M | 69.7M | 78.0M | 85.1M | 9.3% |
| Op CF | -2.4M | 1.9M | 9.6M | 11.1M | 142.0% |
| Inv CF | 0.5M | -4.4M | -0.7M | -1.7M | — |
| Fin CF | -0.3M | -0.3M | -6.1M | -5.9M | — |
Loading...
PRICE (1Y)-22.6%
SMA 50SMA 200
Close
$8.14
RSI (14)
33.8
52W High
$16.28
From 52W High
0.5%
SCORE BREAKDOWN
Quality
62
ROIC
10.7%75.3
ROE
7.2%63.3
GP/Assets
11.0%27.9
Op. Margin
-7.8%30.8
FCF/Assets
2.4%59.7
Piotroski
666.7
Int. Cover
50.0x88.5
D/E Ratio
0.00x99.3
Current Ratio
4.62x68.6
Value
60
P/E (TTM)
12.4x82.1
EV/EBITDA
9.2x71.6
P/FCF
43.1x28.4
P/B
1.1x81.2
P/S
2.1x66.7
Div Yield
1.1%28.7
Momentum
33
52W High %
50%29.9
RS 6M
-100%8.7
SMA 50/200
1.13x84.4
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$100M
P/E (Forward)
—
Gross Margin
23.0%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 106190.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 106190.KQ | High Tech Pharm Co., Ltd.(you) | $100M | 66 | BUY |
| 293480.KS | Hana Pharm Co., Ltd. | $103M | 61 | HOLD |
| 330350.KQ | WITHUS PHARMACEUTICAL Co.,LTD. | $73M | 66 | BUY |
| 271980.KS | Jeil Pharmaceutical Co.,Ltd | $98M | 55 | HOLD |
| 002620.KS | Jeil Pharma Holdings Inc | $68M | 72 | BUY |
| 131030.KQ | DHP Korea Co., Ltd. | $62M | 72 | BUY |
| 054670.KQ | Daehan Nupharm Co.,Ltd. | $51M | 62 | HOLD |
| 008490.KS | Suheung Co., Ltd. | $132M | 79 | BUY |
| 003120.KS | Ilsung Is Co., Ltd. | $91M | 47 | HOLD |
| 176750.KQ | DuChemBIO Co.,Ltd. | $110M | 46 | HOLD |
Peer medians: ROE 0.1% · P/E 16.8x · Gross margin 43.8%